140 related articles for article (PubMed ID: 34974572)
21. Anti-p53 Autoantibody Detection in Automatic Glass Capillary Immunoassay Platform for Screening of Oral Cavity Squamous Cell Carcinoma.
Lin YH; Wu CC; Chen WL; Chang KP
Sensors (Basel); 2020 Feb; 20(4):. PubMed ID: 32054134
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
[TBL] [Abstract][Full Text] [Related]
23. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.
Nylander K; Dabelsteen E; Hall PA
J Oral Pathol Med; 2000 Oct; 29(9):413-25. PubMed ID: 11016683
[TBL] [Abstract][Full Text] [Related]
24. Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients.
Li SX; Yang YQ; Jin LJ; Cai ZG; Sun Z
Cancer Biomark; 2016; 17(4):377-382. PubMed ID: 27662323
[TBL] [Abstract][Full Text] [Related]
25. Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma.
Nakamichi E; Sakakura H; Mii S; Yamamoto N; Hibi H; Asai M; Takahashi M
Oral Dis; 2021 Apr; 27(3):439-447. PubMed ID: 32688445
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Salivary Interleukin-6 in Patients with Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorders, Chronic Periodontitis and in Healthy Controls - A Cross-Sectional Comparative Study.
Rani NAJ; Vardhan BGH; Srinivasan S; Gopal SK
Ann Maxillofac Surg; 2023; 13(1):70-75. PubMed ID: 37711518
[TBL] [Abstract][Full Text] [Related]
27. Lack of association between dental implants and oral squamous cell carcinoma.
Afrashtehfar KI; Almomani MM; Momani M
Evid Based Dent; 2022 Mar; 23(1):40-42. PubMed ID: 35338331
[TBL] [Abstract][Full Text] [Related]
28. P53 auto-antibodies in the sera of patients with oral squamous cell carcinoma.
Friedrich RE; Bartel-Friedrich S; Plambeck K; Bahlo M; Klapdor R
Anticancer Res; 1997; 17(4B):3183-4. PubMed ID: 9329632
[TBL] [Abstract][Full Text] [Related]
29. Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study.
Wang X; Chen S; Chen X; Zhang C; Liang X
J Oral Pathol Med; 2016 Feb; 45(2):83-8. PubMed ID: 26260282
[TBL] [Abstract][Full Text] [Related]
30. Are p53 Antibodies a Diagnostic Indicator for Patients with Oral Squamous Cell Carcinoma? Systematic Review and Meta-Analysis.
Yang ZC; Ling L; Xu ZW; Sui XD; Feng S; Zhang J
Asian Pac J Cancer Prev; 2016; 17(1):109-15. PubMed ID: 26838194
[TBL] [Abstract][Full Text] [Related]
31. [Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck].
Al Kassam D; Alvarez Marcos C; Blanco I; de Los Toyos JR; Llorente JL
Med Clin (Barc); 2007 Dec; 129(20):761-5. PubMed ID: 18093475
[TBL] [Abstract][Full Text] [Related]
32. The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study.
Solomon MC; Vidyasagar MS; Fernandes D; Guddattu V; Mathew M; Shergill AK; Carnelio S; Chandrashekar C
Med Oncol; 2016 Dec; 33(12):138. PubMed ID: 27817107
[TBL] [Abstract][Full Text] [Related]
33. Identification of potential glycoprotein biomarkers in oral squamous cell carcinoma using sweet strategies.
Wong YL; Anand R; Yuen KM; Mustafa WMW; Abraham MT; Tay KK; Rahman ZAA; Chen Y
Glycoconj J; 2021 Feb; 38(1):1-11. PubMed ID: 33547992
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
35. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
36. Sonic Hedgehog is a novel prognostic biomarker in patients with oral squamous cell carcinoma.
Cierpikowski P; Lis-Nawara A; Bar J
Neoplasma; 2021 Jul; 68(4):867-874. PubMed ID: 33998236
[TBL] [Abstract][Full Text] [Related]
37. Retinoblastoma and p53 protein expression in pre-malignant oral lesions and oral squamous cell carcinoma.
de Oliveira MG; Ramalho LM; Gaião L; Pozza DH; de Mello RA
Mol Med Rep; 2012 Jul; 6(1):163-6. PubMed ID: 22576742
[TBL] [Abstract][Full Text] [Related]
38. Detection of circulating anti-p53 antibodies in esophageal cancer patients.
Hagiwara N; Onda M; Miyashita M; Sasajima K
J Nippon Med Sch; 2000 Apr; 67(2):110-7. PubMed ID: 10754600
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of serum p53 protein and p53 antibody in patients with surgical treatment for head and neck squamous cell carcinoma.
Chow V; Yuen AP; Lam KY; Ho WK; Wei WI
Head Neck; 2001 Apr; 23(4):286-91. PubMed ID: 11400229
[TBL] [Abstract][Full Text] [Related]
40. Serum anti-p53 antibodies as a diagnostic tumor marker: observations in patients with malignant and premalignant oral cavity lesions.
Porrini R; Vercellino V; Rocchetti V; Renò F; Giorda E; Pomato E; Cannas M; Sabbatini M
Minerva Stomatol; 2010 May; 59(5):233-9, 239-43. PubMed ID: 20502428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]